Metagenomi Therapeutics MGX Balance Sheet (2023-2026)

NASDAQ MGX
$1.24 +0.04 (+3.25%)
As of: Aug 21, 2026 · 1:05 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation (Quarter) 6.43M11.27M15.96M
Receivables - Accured (Quarter) 1.00M1.30M1.40M1.60M1.60M1.60M1.40M1.30M1.20M1.00M0.90M
Assets
Current Assets
Cash & Equivalents (Quarter) 95.67M51.65M101.90M140.60M102.56M61.18M25.12M27.39M29.20M26.85M32.77M41.72M25.31M39.03M
Receivables - Net (Quarter) 2.08M1.65M0.59M1.10M1.01M0.90M0.96M0.30M
Receivables (Quarter) 2.08M1.65M0.59M1.10M1.01M0.90M0.96M0.30M
Prepaid Assets (Quarter) 4.64M6.16M6.01M7.12M8.40M6.21M5.82M4.75M4.43M4.40M3.80M
Current Assets (Quarter) 278.27M335.64M307.58M282.29M257.96M233.19M211.68M189.82M165.54M144.56M124.47M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 21.54M20.96M20.71M19.72M17.74M16.52M15.11M13.89M12.29M11.16M9.90M
Long-Term Investments (Quarter) 5.65M8.52M8.52M8.52M8.52M10.58M3.45M1.29M2.15M2.15M2.15M2.15M
Other Non-Current Assets (Quarter) 6.07M5.25M5.25M5.25M5.25M5.25M5.25M0.29M5.25M0.81M5.25M5.19M4.39M4.39M
Non-Current Assets (Quarter) 86.57M79.76M78.33M76.06M66.64M64.67M60.60M58.12M55.56M52.40M49.23M
Assets (Quarter) 364.84M415.40M385.90M358.35M324.60M297.87M272.28M247.94M221.10M196.95M173.70M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 1.79M6.84M3.45M3.10M0.53M2.67M2.89M1.22M1.49M2.40M2.60M
Payables (Quarter) 1.79M6.84M3.45M3.10M0.53M2.67M2.89M1.22M1.49M2.40M2.60M
Accumulated Expenses (Quarter) 11.47M7.08M10.98M8.84M8.42M6.12M5.92M9.90M6.72M4.69M7.60M
Other Accumulated Expenses (Quarter) 0.45M0.12M0.28M0.31M0.17M0.23M0.23M
Current Leases (Quarter) 3.43M4.38M5.40M4.70M5.59M5.60M5.51M5.57M6.03M6.11M6.24M
Current Taxes (Quarter) 3.27M3.27M
Current Deferred Revenue (Quarter) 48.07M48.29M32.98M29.05M22.76M25.50M18.94M12.90M8.70M9.31M11.20M
Total Current Liabilities (Quarter) 68.86M70.70M52.81M45.69M37.31M39.89M33.27M29.58M22.93M22.50M27.63M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter) 30.93M20.31M17.33M12.43M10.24M4.37M3.55M1.90M2.99M1.64M
Preferred Stock Liabilities (Quarter) 350.76M350.76M350.76M350.76M
Operating Leases (Quarter) 44.80M43.68M42.55M41.38M40.19M38.83M37.48M36.09M34.63M33.08M31.48M
Other Non-Current Liabilities (Quarter) 5.08M5.08M3.80M3.08M2.01M2.11M2.15M1.92M1.95M1.95M2.02M
Total Non-Current Liabilities (Quarter) 144.59M134.69M112.68M99.50M87.73M83.10M74.30M67.57M60.55M57.22M59.12M
Total Liabilities (Quarter) 149.67M139.77M116.49M102.58M89.74M85.21M76.45M69.49M62.51M59.17M61.13M
Shareholder's Equity
Common Equity (Quarter) -90.01M-102.54M-0.12M-135.58M275.63M269.42M255.77M234.86M212.66M195.83M178.45M158.60M137.78M112.57M
Liabilities and Shareholders Equity (Quarter) 364.84M415.40M385.90M358.35M324.60M297.87M272.28M247.94M221.10M196.95M173.70M
Retained Earnings (Quarter) -0.10M-0.28M-180.80M-199.60M0.71M0.62M-267.90M-288.34M0.26M-0.04M474.10M
Treasury Shares (Quarter) 41.81M41.81M41.81M41.81M0.92M0.50M0.59M0.46M0.43M0.68M0.59M0.06M0.04M0.01M